Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹94 Cr
Revenue (TTM)
₹98 Cr
Net Profit (TTM)
₹4 Cr
ROE
10.6 %
ROCE
10.1 %
P/E Ratio
25.4
P/B Ratio
1.9
Industry P/E
26.59
EV/EBITDA
14.7
Div. Yield
0 %
Debt to Equity
1.5
Book Value
₹48.1
EPS
₹4.7
Face value
10
Shares outstanding
10,127,435
CFO
₹69.77 Cr
EBITDA
₹81.50 Cr
Net Profit
₹30.29 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Godavari Drugs
| 20.7 | 19.3 | 22.2 | 1.3 | 7.0 | 15.2 | 9.1 |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Godavari Drugs
| -30.6 | 20.9 | -5.1 | 51.5 | 62.5 | 120.1 | -31.3 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Godavari Drugs
|
92.7 | 93.9 | 98.2 | 3.7 | 8.1 | 7.9 | 25.4 | 1.9 |
| 2,791.2 | 34,920.1 | 5,201.6 | 1,014.6 | 22.9 | 25 | 34.4 | 7.6 | |
| 7,827.5 | 19,544.3 | 2,177.5 | 200.9 | 11.3 | 26.5 | 97.3 | 23.5 | |
| 1,565.8 | 11,917.5 | 2,089.5 | 622.0 | 31.3 | 20.4 | 19.4 | 3.6 | |
| 1,332.1 | 18,429.0 | 3,078.2 | 469.4 | 26.4 | 14.9 | 42.7 | 5.1 | |
| 1,961.1 | 31,410.1 | 4,193.0 | 753.8 | 22.7 | 20.8 | 41.7 | 7.8 | |
| 4,887.1 | 22,333.8 | 2,482.3 | 853.6 | 33.7 | 18.9 | 26.2 | 5.6 | |
| 4,778.6 | 7,918.9 | 1,348.5 | 293.5 | 28.1 | 50.7 | 27 | 11.4 | |
| 388.9 | 7,603.2 | 1,432.0 | 149.0 | 19.1 | 7.9 | 50.7 | 3.1 | |
| 971.2 | 8,938.5 | 4,725.6 | 528.7 | 14.9 | 20.7 | 17.5 | 3.0 |
No Review & Analysis are available.
Godavari Drugs Limited manufactures and supplies active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. It offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid,... enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. The company also provides loan license and contract manufacturing services. It serves the life science industry. The company was incorporated in 1987 and is based in Secunderabad, India. Read more
Incorporated
1987
Chairman
Ghanshyam Jaju
Managing Director
Mukund Kakani
Headquarters
Secunderabad, Telangana
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Godavari Drugs Ltd is ₹92.70 (BSE) as of 02-Apr-2026 IST. Godavari Drugs Ltd has given a return of 6.97% in the last 3 years.
The P/E ratio of Godavari Drugs Ltd is 25.43 times as on 02-Apr-2026, a 4 discount to its peers’ median range of 26.59 times.
The P/B ratio of Godavari Drugs Ltd is 1.93 times as on 02-Apr-2026, a 57 discount to its peers’ median range of 4.49 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
15.04
|
1.52
|
|
2024
|
12.61
|
1.80
|
|
2023
|
15.07
|
1.71
|
|
2022
|
9.39
|
1.66
|
|
2021
|
8.35
|
1.41
|
The 52-week high and low of Godavari Drugs Ltd are Rs 115.00 and Rs 69.70 as of 05-Apr-2026.
Godavari Drugs Ltd has a market capitalisation of ₹ 94 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Godavari Drugs Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-0.08
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.